ATE325613T1 - Apherese von leukozyten aus blut zur behandlung von hiv - Google Patents

Apherese von leukozyten aus blut zur behandlung von hiv

Info

Publication number
ATE325613T1
ATE325613T1 AT00905345T AT00905345T ATE325613T1 AT E325613 T1 ATE325613 T1 AT E325613T1 AT 00905345 T AT00905345 T AT 00905345T AT 00905345 T AT00905345 T AT 00905345T AT E325613 T1 ATE325613 T1 AT E325613T1
Authority
AT
Austria
Prior art keywords
hiv
leucocytes
blood
treatment
apheresis
Prior art date
Application number
AT00905345T
Other languages
English (en)
Inventor
Masakazu Adachi
Toshifumi Hibi
Original Assignee
Jimro Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11072144A external-priority patent/JP2000262612A/ja
Application filed by Jimro Co Ltd filed Critical Jimro Co Ltd
Application granted granted Critical
Publication of ATE325613T1 publication Critical patent/ATE325613T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00905345T 1999-03-17 2000-02-25 Apherese von leukozyten aus blut zur behandlung von hiv ATE325613T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11072144A JP2000262612A (ja) 1999-03-17 1999-03-17 Ｈｉｖ感染疾患の処置方法
GBGB9919565.3A GB9919565D0 (en) 1999-03-17 1999-08-18 Treatment of disease

Publications (1)

Publication Number Publication Date
ATE325613T1 true ATE325613T1 (de) 2006-06-15

Family

ID=26315857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905345T ATE325613T1 (de) 1999-03-17 2000-02-25 Apherese von leukozyten aus blut zur behandlung von hiv

Country Status (10)

Country Link
US (1) US6498007B1 (de)
EP (1) EP1126859B1 (de)
JP (1) JP4643830B2 (de)
AT (1) ATE325613T1 (de)
AU (1) AU2692900A (de)
DE (1) DE60027863T2 (de)
DK (1) DK1126859T3 (de)
ES (1) ES2262506T3 (de)
PT (1) PT1126859E (de)
WO (1) WO2000055621A2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197249A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US8329388B2 (en) * 1997-07-30 2012-12-11 Cytosorbents, Inc. Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20020198487A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
US20020197252A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
US6878127B2 (en) 2001-04-10 2005-04-12 Renaltech International, Llc Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
DE20121877U1 (de) * 2001-09-27 2003-09-18 LeukoCare GmbH, 85646 Neufarn Leukozyten-Inaktivierungs-Modul (LIM)
JP2003235959A (ja) * 2002-02-14 2003-08-26 Nippon Koutai Kenkyusho:Kk Ｃ型肝炎ウイルスの除去・減量方法
JP4925829B2 (ja) * 2004-08-30 2012-05-09 株式会社カネカ 顆粒球吸着材
WO2006028202A1 (ja) * 2004-09-10 2006-03-16 Kaneka Corporation リンパ球増殖抑制因子の吸着材及び処理方法
JPWO2006106763A1 (ja) * 2005-03-30 2008-09-11 株式会社カネカ リンパ球増殖抑制因子の除去方法
KR100647335B1 (ko) 2005-04-15 2006-11-23 삼성전자주식회사 소수성 고체 지지체를 이용한 세포 분리 방법
EP1712284B1 (de) * 2005-04-15 2012-10-10 Samsung Electronics Co., Ltd. Methode zur Zelltrennung mit Benutzung hydrophober fester Träger
CN101267850B (zh) 2005-09-09 2011-05-11 门布拉内有限公司 从血液中去除白细胞的方法
US20100135976A1 (en) * 2006-06-16 2010-06-03 Rune Nilsson Adsorption device
KR100813264B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
US8158411B2 (en) * 2006-08-21 2012-04-17 Samsung Electronics Co., Ltd. Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same
JP2008048735A (ja) * 2006-08-21 2008-03-06 Samsung Electronics Co Ltd 非平面状の固体支持体を用いた微生物の分離方法及び分離装置
KR100917465B1 (ko) * 2006-08-21 2009-09-14 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물을 분리하는방법 및 미생물분리 장치
KR100813265B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
CA2664770C (en) * 2006-09-29 2014-05-27 Toray Industries, Inc. Cell adsorption column
KR101427609B1 (ko) * 2007-01-13 2014-08-07 멤브라나 게엠베하 혈액으로부터 백혈구를 제거하는 장치
EP2187957A4 (de) 2007-08-31 2011-08-24 Univ Michigan Selektive cytopheresevorrichtungen und entsprechende verfahren
US20090149802A1 (en) * 2007-12-07 2009-06-11 Ross Peter Jones Surgical System Including a Trap for Noise-Inducing Materials
PH12012500702A1 (en) * 2009-10-08 2012-10-29 Otsuka Pharma Co Ltd An immunoactivation blood perfusion filter for the treatment of malignant tumors
US20130288370A1 (en) 2010-10-15 2013-10-31 Cytopherx, Inc. Cytopheresis cartridges and use thereof
DE102010049790A1 (de) * 2010-10-29 2012-05-03 Fresenius Medical Care Deutschland Gmbh Medizinische Trennvorrichtung
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
EP2606921A1 (de) 2011-12-21 2013-06-26 Infomed SA Vorrichtung zur Blutreinigung durch extrakorporale Zirkulation
CA2860831C (en) 2012-01-09 2024-09-10 Seastar Medical, Inc. CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
WO2014192908A1 (ja) * 2013-05-31 2014-12-04 東レ株式会社 吸着担体充填カラム
EP3185926B1 (de) 2014-08-26 2018-11-28 3M Innovative Properties Company System zur entfernung von proinflammatorischen mediatoren sowie von granulozyten und monozyten aus blut
US11383015B2 (en) * 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
CN106267410B (zh) * 2016-07-01 2019-03-08 翁炳焕 艾滋病感染细胞分离器
CN106166313B (zh) * 2016-07-01 2018-09-07 浙江大学 一种艾滋病孕妇血液净化器
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
WO2019136289A1 (en) 2018-01-05 2019-07-11 Path Ex, Inc. Device for the capture and removal of disease material from fluids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
JP2673567B2 (ja) 1987-12-10 1997-11-05 株式会社日本抗体研究所 血液中の顆粒球除去方法及びこれに用いる顆粒球除去装置
US5807881A (en) 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5567443A (en) * 1993-08-04 1996-10-22 Japan Immunoresearch Laboratories Co., Ltd. Method of treating inflammatory diseases
US5525279A (en) 1994-04-04 1996-06-11 Sekisui Kagaku Kogyo K.K. Method of forming a granulocyte adsorbing carrier and granulocyte remover

Also Published As

Publication number Publication date
DE60027863T2 (de) 2006-12-07
JP4643830B2 (ja) 2011-03-02
WO2000055621A3 (en) 2001-04-19
DK1126859T3 (da) 2006-08-28
WO2000055621A8 (en) 2001-07-05
EP1126859A2 (de) 2001-08-29
EP1126859B1 (de) 2006-05-10
WO2000055621A2 (en) 2000-09-21
PT1126859E (pt) 2006-09-29
JP2002539178A (ja) 2002-11-19
ES2262506T3 (es) 2006-12-01
DE60027863D1 (de) 2006-06-14
AU2692900A (en) 2000-10-04
US6498007B1 (en) 2002-12-24

Similar Documents

Publication Publication Date Title
DE60027863D1 (de) Apherese von leukozyten aus blut zur behandlung von hiv
NO920834D0 (no) Fremgangsmaate for inaktivering av virus i blod og blodprodukter
ATE54828T1 (de) Behandlung von auf einer festen phase adsorbierten biologischen und pharmazeutischen produkten mit viren und pyrogenen inaktivierenden agenzien.
DE69638094D1 (de) Verfahren und vorrichtungen zur entfernung von psoralenen aus blutprodukten.
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
ATE194921T1 (de) Verfahren zur inaktivierung von viren
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
FI960281A0 (fi) Menetelmä tuotteiden sterilisoimiseksi
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
ATE195891T1 (de) Sorbentmittel und dessen herstellungsverfahren
MX9206303A (es) Trombina y metodo para producir la misma.
DE68915045D1 (de) Reinigung von Pertussis-Toxinen und Herstellung von Vakzine.
EP1044696A3 (de) Entfernung von hüllehaltigen Viren aus Blut, Plasma oder Serum
ATE516034T1 (de) Verfahren zur modulation der immunreaktion in einem infektierten säugetier mittels transmukosales eingeben eines modulationsmittel
DE3855127D1 (de) Methode zur Entfernung von Granulozyten aus dem Blut und Gerät dafür
ATE189394T1 (de) Methode zur behandlung von viralen infektionen
SE7808686L (sv) Forfarande for pavisning av alstrare i blod
DE69833256D1 (de) Methode zur entfernung von endotoxinen aus impstoffen
DE69811628D1 (de) Verfahren zur Entfernung von Erregern übertragbarer spongiformer Encephalophatien aus Proteinlösungen
ATE526977T1 (de) Verfahren zur inaktivierung infektioeser erreger in biologischen flüssigkeiten
DE59209133D1 (de) Verfahren zur Herstellung eines virussicheren Thrombinkonzentrates
DK0764049T3 (da) Alkalibestandigt proteinadsorptionsmiddel
SE9402523L (sv) Sätt att behandla ett igensatt poröst medium
WO1990013281A3 (en) Method of suppressing hiv infection
ATE180672T1 (de) Verfahren zur herstellung von infektionsfreien pharmazeutischen präparaten und/oder nahrungsmitteln aus infektiösem, insbesondere prionen enthaltendem, material

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1126859

Country of ref document: EP

EEIH Change in the person of patent owner